Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
2020 | ACell, Inc. Announces CE Mark Approval | CI |
Sales 2018 | 89.22M 7.14B | Sales 2019 | 101M 8.07B | Capitalization | 340M 27.23B |
---|---|---|---|---|---|
Net income 2018 | -3M -240M | Net income 2019 | 1M 80.05M | EV / Sales 2018 * | - |
Net cash position 2018 * | - 0 | Net cash position 2019 * | - 0 | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 31/03/13 |
Patty Meehan
ADM | Chief Administrative Officer | - | 31/12/01 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | - | |
Director/Board Member | 69 | 30/06/19 | |
Kyle C. Kerbawy
BRD | Director/Board Member | 77 | 31/07/15 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 340M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ACLL Stock